Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
CNY 15.77
(3.0%)
CNY 15.77
(3.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 125.12 Million CNY | -9.48% |
| 2022 | 138.21 Million CNY | -11.35% |
| 2021 | 155.91 Million CNY | 46.23% |
| 2020 | 106.62 Million CNY | -19.03% |
| 2019 | 131.68 Million CNY | 0.54% |
| 2018 | 130.97 Million CNY | 28.42% |
| 2017 | 101.98 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 11.33 Million CNY | 9.14% |
| 2024 Q1 | 26.36 Million CNY | -27.66% |
| 2024 Q2 | 10.38 Million CNY | -60.6% |
| 2023 FY | 125.12 Million CNY | -9.48% |
| 2023 Q3 | 28.93 Million CNY | -18.97% |
| 2023 Q4 | 36.44 Million CNY | 25.95% |
| 2023 Q1 | 24.04 Million CNY | -26.78% |
| 2023 Q2 | 35.7 Million CNY | 48.51% |
| 2022 Q2 | 36.44 Million CNY | 12.29% |
| 2022 Q1 | 32.45 Million CNY | -16.98% |
| 2022 FY | 138.21 Million CNY | -11.35% |
| 2022 Q4 | 32.83 Million CNY | -9.98% |
| 2022 Q3 | 36.47 Million CNY | 0.08% |
| 2021 Q1 | 37.12 Million CNY | 3.19% |
| 2021 FY | 155.91 Million CNY | 46.23% |
| 2021 Q4 | 39.09 Million CNY | 9.02% |
| 2021 Q3 | 35.86 Million CNY | -18.17% |
| 2021 Q2 | 43.82 Million CNY | 18.05% |
| 2020 Q4 | 35.97 Million CNY | -86.91% |
| 2020 Q3 | 274.93 Million CNY | 611.38% |
| 2020 Q2 | 38.64 Million CNY | 553.41% |
| 2020 Q1 | 5.91 Million CNY | -94.7% |
| 2020 FY | 106.62 Million CNY | -19.03% |
| 2019 Q4 | 111.59 Million CNY | 0.0% |
| 2019 FY | 131.68 Million CNY | 0.54% |
| 2018 FY | 130.97 Million CNY | 28.42% |
| 2017 FY | 101.98 Million CNY | 0.0% |